Cansino Biologics (China) Price History
| 688185 Stock | 67.55 0.94 1.37% |
Below is the normalized historical share price chart for Cansino Biologics extending back to August 13, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cansino Biologics stands at 67.55, as last reported on the 12th of December 2024, with the highest price reaching 69.85 and the lowest price hitting 67.45 during the day.
If you're considering investing in Cansino Stock, it is important to understand the factors that can impact its price. Cansino Biologics is not too volatile given 3 months investment horizon. Cansino Biologics secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19% return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.03% are justified by taking the suggested risk. Use Cansino Biologics Risk Adjusted Performance of 0.142, downside deviation of 4.11, and Mean Deviation of 3.16 to evaluate company specific risk that cannot be diversified away.
At present, Cansino Biologics' Stock Based Compensation is projected to decrease significantly based on the last few years of reporting. The current year's Sale Purchase Of Stock is expected to grow to about 17.9 M, whereas Total Stockholder Equity is forecasted to decline to about 4.5 B. . Cansino Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 50.0035 | 50 Day MA 60.0816 | Beta 0.49 |
Cansino |
Sharpe Ratio = 0.1871
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 688185 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.49 actual daily | 48 52% of assets are more volatile |
Expected Return
| 1.03 actual daily | 20 80% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Cansino Biologics is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cansino Biologics by adding it to a well-diversified portfolio.
Price Book 3.3497 | Enterprise Value Ebitda (3.94) | Price Sales 15.8577 | Shares Float 126.9 M | Wall Street Target Price 61.34 |
Cansino Biologics Stock Price History Chart
There are several ways to analyze Cansino Stock price data. The simplest method is using a basic Cansino candlestick price chart, which shows Cansino Biologics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 11, 2024 | 73.75 |
| Lowest Price | September 9, 2024 | 38.7 |
Cansino Biologics December 12, 2024 Stock Price Synopsis
Various analyses of Cansino Biologics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cansino Stock. It can be used to describe the percentage change in the price of Cansino Biologics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cansino Stock.| Cansino Biologics Price Action Indicator | (1.57) | |
| Cansino Biologics Price Rate Of Daily Change | 0.99 | |
| Cansino Biologics Accumulation Distribution | 65,004 | |
| Cansino Biologics Price Daily Balance Of Power | (0.39) |
Cansino Biologics December 12, 2024 Stock Price Analysis
Cansino Stock Price History Data
The price series of Cansino Biologics for the period between Fri, Sep 13, 2024 and Thu, Dec 12, 2024 has a statistical range of 35.05 with a coefficient of variation of 19.18. The prices are distributed with arithmetic mean of 55.64. The median price for the last 90 days is 56.58. The company issued dividends on 2022-08-23.| Open | High | Low | Close | Volume | ||
| 12/11/2024 | 68.49 | 69.85 | 67.45 | 67.55 | 1,891,883 | |
| 12/10/2024 | 70.50 | 70.55 | 68.29 | 68.49 | 2,406,197 | |
| 12/09/2024 | 70.28 | 70.90 | 67.65 | 68.29 | 2,377,146 | |
| 12/06/2024 | 67.48 | 70.53 | 67.04 | 70.37 | 3,470,228 | |
| 12/05/2024 | 65.94 | 67.37 | 65.49 | 67.04 | 1,632,649 | |
| 12/04/2024 | 67.65 | 67.65 | 65.10 | 65.66 | 2,038,968 | |
| 12/03/2024 | 68.13 | 68.36 | 66.21 | 67.66 | 2,274,642 | |
| 12/02/2024 | 66.50 | 68.45 | 65.81 | 67.99 | 2,548,683 | |
| 11/29/2024 | 64.68 | 66.88 | 63.34 | 66.50 | 2,565,965 | |
| 11/28/2024 | 64.51 | 65.50 | 63.51 | 65.50 | 2,257,211 | |
| 11/27/2024 | 64.88 | 65.22 | 62.25 | 64.50 | 1,910,335 | |
| 11/26/2024 | 63.75 | 66.50 | 63.29 | 63.88 | 2,281,607 | |
| 11/25/2024 | 62.15 | 64.20 | 62.15 | 63.90 | 2,306,955 | |
| 11/22/2024 | 67.70 | 67.88 | 62.08 | 62.11 | 3,030,696 | |
| 11/21/2024 | 67.23 | 69.31 | 66.16 | 67.12 | 2,409,264 | |
| 11/20/2024 | 65.94 | 68.46 | 65.94 | 67.60 | 3,195,963 | |
| 11/19/2024 | 62.79 | 66.70 | 62.12 | 66.06 | 3,918,001 | |
| 11/18/2024 | 63.95 | 64.89 | 61.35 | 61.94 | 2,437,068 | |
| 11/15/2024 | 67.23 | 68.38 | 63.90 | 63.96 | 2,887,276 | |
| 11/14/2024 | 70.63 | 70.63 | 67.52 | 67.52 | 2,599,354 | |
| 11/13/2024 | 68.99 | 71.28 | 67.57 | 70.65 | 5,095,137 | |
| 11/12/2024 | 72.70 | 75.00 | 69.16 | 69.46 | 8,318,288 | |
| 11/11/2024 | 61.35 | 73.75 | 60.90 | 73.75 | 7,250,142 | |
| 11/08/2024 | 61.52 | 62.79 | 60.80 | 61.46 | 3,277,745 | |
| 11/07/2024 | 58.69 | 60.30 | 58.11 | 60.19 | 2,245,231 | |
| 11/06/2024 | 57.60 | 61.75 | 57.10 | 59.13 | 3,746,552 | |
| 11/05/2024 | 56.00 | 57.64 | 55.16 | 57.50 | 2,198,113 | |
| 11/04/2024 | 55.40 | 56.22 | 54.73 | 55.93 | 1,620,433 | |
| 11/01/2024 | 56.67 | 57.22 | 54.66 | 54.66 | 2,631,620 | |
| 10/31/2024 | 57.89 | 58.50 | 56.41 | 56.58 | 2,833,410 | |
| 10/30/2024 | 56.14 | 59.90 | 56.00 | 57.84 | 3,995,829 | |
| 10/29/2024 | 58.14 | 58.46 | 55.66 | 55.81 | 2,692,015 | |
| 10/28/2024 | 57.09 | 57.70 | 56.00 | 57.37 | 1,990,934 | |
| 10/25/2024 | 55.74 | 57.98 | 55.74 | 57.10 | 2,486,325 | |
| 10/24/2024 | 56.17 | 57.53 | 55.73 | 56.00 | 2,590,874 | |
| 10/23/2024 | 56.44 | 57.16 | 55.78 | 56.28 | 2,628,900 | |
| 10/22/2024 | 54.89 | 56.73 | 54.22 | 55.78 | 2,806,781 | |
| 10/21/2024 | 53.72 | 55.91 | 53.44 | 54.76 | 2,969,018 | |
| 10/18/2024 | 50.60 | 55.28 | 50.50 | 53.80 | 3,172,129 | |
| 10/17/2024 | 51.31 | 52.42 | 50.73 | 50.73 | 1,726,858 | |
| 10/16/2024 | 51.07 | 52.25 | 50.62 | 50.99 | 1,739,445 | |
| 10/15/2024 | 53.00 | 54.20 | 51.88 | 51.89 | 2,174,335 | |
| 10/14/2024 | 53.05 | 54.15 | 51.01 | 53.65 | 2,753,221 | |
| 10/11/2024 | 59.19 | 59.19 | 51.73 | 53.00 | 3,432,938 | |
| 10/10/2024 | 59.00 | 60.97 | 57.30 | 57.45 | 4,500,156 | |
| 10/09/2024 | 61.50 | 63.13 | 56.40 | 56.48 | 5,626,043 | |
| 10/08/2024 | 66.00 | 66.16 | 58.03 | 64.10 | 7,416,239 | |
| 09/30/2024 | 48.50 | 55.20 | 48.48 | 55.18 | 5,920,120 | |
| 09/27/2024 | 43.92 | 46.05 | 43.75 | 46.00 | 2,033,847 | |
| 09/26/2024 | 41.25 | 43.18 | 41.20 | 43.06 | 1,840,670 | |
| 09/25/2024 | 41.56 | 42.51 | 41.30 | 41.41 | 2,066,440 | |
| 09/24/2024 | 39.86 | 41.15 | 39.52 | 41.14 | 1,797,000 | |
| 09/23/2024 | 41.14 | 41.23 | 39.46 | 39.64 | 1,569,788 | |
| 09/20/2024 | 40.96 | 40.98 | 39.94 | 40.59 | 1,141,247 | |
| 09/19/2024 | 41.57 | 41.68 | 40.68 | 41.00 | 1,475,232 | |
| 09/18/2024 | 40.86 | 41.73 | 40.86 | 41.26 | 1,322,925 | |
| 09/13/2024 | 40.63 | 41.17 | 40.40 | 40.84 | 1,163,098 | |
| 09/12/2024 | 39.66 | 40.98 | 39.66 | 40.63 | 1,676,023 | |
| 09/11/2024 | 39.38 | 40.00 | 38.96 | 39.66 | 932,033 | |
| 09/10/2024 | 38.98 | 39.49 | 38.21 | 39.18 | 762,915 | |
| 09/09/2024 | 39.00 | 39.64 | 38.65 | 38.70 | 821,906 |
About Cansino Biologics Stock history
Cansino Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cansino is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cansino Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cansino Biologics stock prices may prove useful in developing a viable investing in Cansino Biologics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 284.6 M | 259.1 M | |
| Net Loss | -1 B | -993.6 M |
Cansino Biologics Quarterly Net Working Capital |
|
Cansino Biologics Stock Technical Analysis
Cansino Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Cansino Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cansino Biologics' price direction in advance. Along with the technical and fundamental analysis of Cansino Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cansino to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.142 | |||
| Jensen Alpha | 0.9315 | |||
| Total Risk Alpha | 0.1242 | |||
| Sortino Ratio | 0.2002 | |||
| Treynor Ratio | 20.15 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Cansino Stock analysis
When running Cansino Biologics' price analysis, check to measure Cansino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cansino Biologics is operating at the current time. Most of Cansino Biologics' value examination focuses on studying past and present price action to predict the probability of Cansino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cansino Biologics' price. Additionally, you may evaluate how the addition of Cansino Biologics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |